(S,Z)-4-amino-N-(4-fluorobicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide

ID: ALA4475809

PubChem CID: 137297358

Max Phase: Preclinical

Molecular Formula: C11H10FN5O2

Molecular Weight: 263.23

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Nc1nonc1/C(=N/O)N[C@H]1Cc2ccc(F)cc21

Standard InChI:  InChI=1S/C11H10FN5O2/c12-6-2-1-5-3-8(7(5)4-6)14-11(15-18)9-10(13)17-19-16-9/h1-2,4,8,18H,3H2,(H2,13,17)(H,14,15)/t8-/m0/s1

Standard InChI Key:  ZYPFVFRPQQRTIM-QMMMGPOBSA-N

Molfile:  

 
     RDKit          2D

 19 21  0  0  0  0  0  0  0  0999 V2000
   33.5420  -11.5852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3591  -11.5852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6135  -10.8085    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.9506  -10.3263    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.2918  -10.8085    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.8387  -12.2468    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.0608  -12.2457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2482  -12.1592    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.3922  -12.9926    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.9110  -13.6531    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.9167  -11.4122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2114  -10.6505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1550  -11.1192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4494  -10.3604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9399   -9.7281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1359   -9.8533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8440  -10.6165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3554  -11.2456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0371  -10.7455    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  1  2  0
  2  6  1  0
  1  7  1  0
  7  8  1  0
  7  9  2  0
  9 10  1  0
 11  8  1  6
 11 12  1  0
 12 14  1  0
 13 11  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 17 19  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4475809

    ---

Associated Targets(Human)

IDO1 Tchem Indoleamine 2,3-dioxygenase (6650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 263.23Molecular Weight (Monoisotopic): 263.0819AlogP: 0.81#Rotatable Bonds: 2
Polar Surface Area: 109.56Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 6.31CX Basic pKa: CX LogP: 0.88CX LogD: -0.22
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.32Np Likeness Score: -1.30

References

1. Zhang H, Liu K, Pu Q, Achab A, Ardolino MJ, Cheng M, Deng Y, Doty AC, Ferguson H, Fradera X, Knemeyer I, Kurukulasuriya R, Lam YH, Lesburg CA, Martinot TA, McGowan MA, Miller JR, Otte K, Biju PJ, Sciammetta N, Solban N, Yu W, Zhou H, Wang X, Bennett DJ, Han Y..  (2019)  Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy.,  10  (11): [PMID:31749906] [10.1021/acsmedchemlett.9b00344]

Source